These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3083339)

  • 41. Immunohistopathology of Sjögren's syndrome.
    Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
    Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lessons from diseases mimicking Sjögren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Font J
    Clin Rev Allergy Immunol; 2007 Jun; 32(3):275-83. PubMed ID: 17992594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease?
    Mavragani CP; Fragoulis GE; Rontogianni D; Kanariou M; Moutsopoulos HM
    Arthritis Care Res (Hoboken); 2014 May; 66(5):773-7. PubMed ID: 25100215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative and visual evaluation of salivary and thyroid glands in patients with primary Sjögren's syndrome using salivary gland scintigraphy: relationship with clinicopathological features of salivary, lacrimal and thyroid glands.
    Güne S; Yilmaz S; Karalezli A; Aktaş A
    Nucl Med Commun; 2010 Jul; 31(7):666-72. PubMed ID: 20545046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optic neuropathy as an initial manifestation of Sjögren's syndrome.
    Wise CM; Agudelo CA
    J Rheumatol; 1988; 15(5):799-802. PubMed ID: 3262752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study.
    Loustaud-Ratti V; Riche A; Liozon E; Labrousse F; Soria P; Rogez S; Babany G; Delaire L; Denis F; Vidal E
    J Rheumatol; 2001 Oct; 28(10):2245-51. PubMed ID: 11669164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
    Suresh L; Malyavantham K; Shen L; Ambrus JL
    BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achalasia sicca--juvenile Sjögren's syndrome with achalasia and gastric hyposecretion.
    Similä S; Kokkonen J; Kaski M
    Eur J Pediatr; 1978 Oct; 129(3):175-81. PubMed ID: 699923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do we need new diagnostic criteria for Sjögren's syndrome?
    Daniels TE
    Presse Med; 2012 Sep; 41(9 Pt 2):e441-9. PubMed ID: 22840994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-mortem prevalence of lymphocytic infiltration of the lacrymal gland: a comparative study in autoimmune and non-autoimmune diseases.
    Nasu M; Matsubara O; Yamamoto H
    J Pathol; 1984 May; 143(1):11-5. PubMed ID: 6737113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High prevalence of subclinical Sjögren's syndrome features in patients with autoimmune thyroid disease.
    Coll J; Anglada J; Tomas S; Reth P; Goday A; Millan M; Pujol-Borrell R; Corominas J
    J Rheumatol; 1997 Sep; 24(9):1719-24. PubMed ID: 9292794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.
    Ng KP; Isenberg DA
    Drugs Aging; 2008; 25(1):19-33. PubMed ID: 18184026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Juvenile Sjögren's syndrome: case report].
    Susić G; Stojanović R; Milić V; Boricić I; Mandić B; Milenković S
    Srp Arh Celok Lek; 2013; 141(3-4):228-31. PubMed ID: 23745349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
    Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G
    Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
    Safonova TN; Iudina IuV
    Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical and pathological features of Sjögren's syndrome associated with autoimmune thyroid diseases].
    Ichikawa Y; Fukuda R
    Nihon Rinsho; 1995 Oct; 53(10):2545-50. PubMed ID: 8531371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can low dose diagnostic dental radiation trigger Sjögren's syndrome?
    Kurien BT; Mathews SA; Scofield RH
    Med Hypotheses; 2007; 69(5):995-1000. PubMed ID: 17442501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.